Please use this identifier to cite or link to this item: https://dora.health.qld.gov.au/qldresearchjspui/handle/1/6192
Full metadata record
DC FieldValueLanguage
dc.contributor.authorWallington-Gates, Craig Thomasen
dc.contributor.authorMynott, R.L.en
dc.date.accessioned2024-08-08T03:22:00Z-
dc.date.available2024-08-08T03:22:00Z-
dc.date.issued2021-
dc.identifier.citationResearchSquare, 2021en
dc.identifier.urihttps://dora.health.qld.gov.au/qldresearchjspui/handle/1/6192-
dc.titlePrognostic and Therapeutic Biomarker Developments in Multiple Myelomaen
dc.typeArticleen
dc.identifier.doi10.21203/rs.3.rs-578394-
dc.identifier.scopus2-s2.0-85132490569-
dc.rights.holderCraig Wallington-Gatesen
dc.identifier.journaltitleResearchSquare-
dc.identifier.external135967590-
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
item.openairetypeArticle-
Appears in Sites:Sunshine Coast HHS Publications
Show simple item record

Page view(s)

78
checked on Dec 21, 2024

Google ScholarTM

Check

Altmetric


Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.